Last update 16 May 2025

Omilancor

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
BT11, BT 11, BT-11
Action
stimulants, inhibitors
Mechanism
LANCL2 stimulants(LanC like 2 stimulants), MAP2K6 inhibitors(mitogen-activated protein kinase kinase 6 inhibitors)
Originator Organization
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC30H24N8O2
InChIKeyMVHWZNBAQIGPOQ-UHFFFAOYSA-N
CAS Registry1912399-75-7

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Crohn DiseasePhase 2
United States
04 May 2021
Colitis, UlcerativePhase 2
United States
14 Aug 2019
Colitis, UlcerativePhase 2
Bosnia and Herzegovina
14 Aug 2019
Colitis, UlcerativePhase 2
Croatia
14 Aug 2019
Colitis, UlcerativePhase 2
Poland
14 Aug 2019
Colitis, UlcerativePhase 2
Ukraine
14 Aug 2019
Eosinophilic EsophagitisPhase 1-30 Jan 2022
Intervertebral Disc DegenerationPreclinical
China
20 Mar 2024
Dermatitis, AtopicPreclinical
United States
30 Apr 2021
PsoriasisPreclinical
United States
18 Apr 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
27
(BT-11 880 mg)
cwnosxwkik = urgqutqecx zitskuvimd (ntlidfhwil, iximwxtwjo - sbclsagvea)
-
04 Dec 2023
Placebo
(Placebo)
cwnosxwkik = uombketsjf zitskuvimd (ntlidfhwil, zqgrdglrwa - mceuwoxcyx)
Phase 2
198
(BT-11 Low-dose (440 mg))
ixhvtslwqj = wqanejqeub fdxperhqjn (svxaonmcpg, jlrclektbc - plxncohkub)
-
03 Nov 2022
(BT-11 High-dose (880 mg))
ixhvtslwqj = dfclgvihjk fdxperhqjn (svxaonmcpg, cmverqtehw - rqspcxisrf)
Phase 2
Colitis, Ulcerative
fecal calprotectin (FCP) | PK profiles of omilancor in stool | colonic tissue and plasma
-
vqwjrqvjhm(taxtvhneif) = ktsnnuizyk ldmyjxbgxl (cetrrxwrqf )
Positive
02 Oct 2021
vqwjrqvjhm(taxtvhneif) = ymaofnrdva ldmyjxbgxl (cetrrxwrqf )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free